Unbiased Plasma Proteomics Expands GWAS Insights

Genome-wide association studies have identified thousands of disease-associated genetic variants, yet translating these findings into actionable biological and therapeutic insights remains a major challenge. In this webinar, Karsten Suhre, PhD, examines how unbiased plasma proteomics can strengthen target discovery, target validation, biomarker interpretation, and disease-mechanism research by integrating proteomic and genetic evidence.

Learn how peptide-level measurements can help distinguish true biological signals from platform artifacts and genetic confounders, enabling greater confidence in causal biology and more informed therapeutic decisions across translational research, clinical studies, and population-scale biobanks.